Stock Analyses
Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.
All sectors 6,479
Financial Services 1,900
Healthcare 1,116
Technology 1,079
Industrials 668
Consumer Cyclical 490
Basic Materials 337
Consumer Defensive 248
Communication Services 213
Utilities 183
Energy 165
Real Estate 80
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
DMAA
Valuation N/A
Drugs Made In America Acquisition Corp.
Price$10.80
Model IV—
P/IV—
DMAAR
Valuation N/A
Drugs Made In America Acquisition Corp.
Price$0.13
Model IV—
P/IV—
DMAAU
Valuation N/A
Drugs Made In America Acquisition Corp.
Price$10.79
Model IV—
P/IV—
DMAC
Valuation N/A
DiaMedica Therapeutics Inc.
Price$6.47
Model IV—
P/IV—
DMB
Valuation N/A
BNY Mellon Municipal Bond Infrastructure Fund, Inc.
Price$9.89
Model IV—
P/IV—
DMII
Valuation N/A
Drugs Made In America Acquisition II Corp.
Price$10.16
Model IV—
P/IV—
DMIIR
Valuation N/A
Drugs Made In America Acquisition II Corp.
Price$0.08
Model IV—
P/IV—
DMIIU
Valuation N/A
Drugs Made In America Acquisition II Corp.
Price$10.20
Model IV—
P/IV—
DMLP
Deeply undervalued
DORCHESTER MINERALS, L.P.
Price$29.55
Model IV$56.62
P/IV0.48
Discount 48%
Return to IV: +91.6%
Market implies -2.8%/yr
vs model +8.0% · below model
DMO
Valuation N/A
Western Asset Mortgage Opportunity Fund Inc.
Price$9.89
Model IV—
P/IV—
DMRA
Valuation N/A
Damora Therapeutics, Inc.
Price$28.39
Model IV—
P/IV—
DMRC
Valuation N/A
Digimarc Corp
Price$5.04
Model IV—
P/IV—
DNA
Valuation N/A
Ginkgo Bioworks Holdings, Inc.
Price$6.75
Model IV—
P/IV—
Market implies +54.2%/yr
vs model +2.0% · above model
DNLI
Valuation N/A
Denali Therapeutics Inc.
Price$21.09
Model IV—
P/IV—
Market implies +33.7%/yr
vs model +15.0% · above model
DNMX
Valuation N/A
Dynamix Corp III
Price$10.07
Model IV—
P/IV—
DNMXU
Valuation N/A
Dynamix Corp III
Price$10.16
Model IV—
P/IV—
DNMXW
Valuation N/A
Dynamix Corp III
Price$0.23
Model IV—
P/IV—
DNN
Valuation N/A
DENISON MINES CORP.
Price$3.02
Model IV—
P/IV—
DNOW
Deeply undervalued
DNOW Inc.
Price$15.65
Model IV$23.60
P/IV0.54
Discount 34%
Return to IV: +50.8%
Owner yield 10.7%
10-yr IRR 25.2% · grower
Market implies +4.0%/yr
vs model +12.1% · below model
DNP
Valuation N/A
DNP SELECT INCOME FUND INC
Price$10.57
Model IV—
P/IV—
DNTH
Valuation N/A
Dianthus Therapeutics, Inc. /DE/
Price$106.20
Model IV—
P/IV—
Market implies +116.9%/yr
vs model +15.0% · above model
DNUT
Deeply undervalued
Krispy Kreme, Inc.
Price$3.20
Model IV$4.87
P/IV0.72
Discount 34%
Return to IV: +52.3%
Market implies -8.7%/yr
vs model +3.2% · below model
DOC
Undervalued
HEALTHPEAK PROPERTIES, INC.
Price$20.33
Model IV$25.57
P/IV0.75
Discount 20%
Return to IV: +25.8%
DOCN
Valuation N/A
DigitalOcean Holdings, Inc.
Price$122.95
Model IV—
P/IV—
Market implies +32.8%/yr
vs model +20.4% · above model
DOCS
Undervalued
Doximity, Inc.
Price$25.81
Model IV$32.47
P/IV0.66
Discount 21%
Return to IV: +25.8%
Owner yield 5.1%
10-yr IRR 15.2% · grower
Market implies +9.5%/yr
vs model +15.5% · below model
DOCU
Deeply undervalued
DOCUSIGN, INC.
Price$65.65
Model IV$217.76
P/IV0.22
Discount 70%
Return to IV: +231.7%
Owner yield 4.6%
10-yr IRR 13.9% · grower
Market implies +2.2%/yr
vs model +24.4% · below model
DOGZ
Undervalued
Dogness (International) Corp
Price$0.92
Model IV$1.22
P/IV0.84
Discount 25%
Return to IV: +32.9%
Market implies -12.9%/yr
vs model +2.0% · below model
DOLE
Deeply undervalued
Dole plc
Price$13.33
Model IV$47.80
P/IV0.29
Discount 72%
Return to IV: +258.6%
Owner yield 10.5%
10-yr IRR 21.2% · moderate
Market implies -11.0%/yr
vs model +8.0% · below model
DOMH
Deeply undervalued
Dominari Holdings Inc.
Price$2.23
Model IV$4.40
P/IV0.84
Discount 49%
Return to IV: +97.4%
Market implies -8.6%/yr
vs model +15.0% · below model
DOMO
Overvalued
DOMO, INC.
Price$3.83
Model IV$3.32
P/IV1.25
Premium +15%
Return to IV: -13.2%
Market implies +5.7%/yr
vs model +5.4% · in line
DOO
Valuation N/A
BRP Inc.
Price$58.92
Model IV—
P/IV—
DORM
Deeply overvalued
Dorman Products, Inc.
Price$126.66
Model IV$44.39
P/IV2.79
Premium +185%
Return to IV: -65.0%
Owner yield 3.7%
10-yr IRR 5.6% · moderate
Market implies +20.7%/yr
vs model +8.0% · above model
DOUG
Deeply undervalued
Douglas Elliman Inc.
Price$1.68
Model IV$5.80
P/IV0.31
Discount 71%
Return to IV: +245.1%
Market implies -21.1%/yr
vs model +2.0% · below model
DOV
Deeply overvalued
DOVER Corp
Price$187.42
Model IV$112.91
P/IV0.11
Premium +66%
Return to IV: -39.8%
Owner yield 4.0%
10-yr IRR 3.8% · steady
Market implies +9.6%/yr
vs model +4.3% · above model
DOW
Deeply undervalued
DOW INC.
Price$28.73
Model IV$46.69
P/IV0.72
Discount 38%
Return to IV: +62.5%
Owner yield 2.2%
10-yr IRR -6.1% · steady
Market implies -9.3%/yr
vs model +0.0% · below model
DOX
Deeply undervalued
AMDOCS LTD
Price$61.42
Model IV$117.26
P/IV0.54
Discount 48%
Return to IV: +90.9%
Owner yield 8.7%
10-yr IRR 20.0% · moderate
Market implies -0.2%/yr
vs model +10.4% · below model
DOYU
Deeply undervalued
DouYu International Holdings Ltd
Price$4.75
Model IV$23.27
P/IV0.23
Discount 80%
Return to IV: +390.0%
Market implies -31.4%/yr
vs model +2.0% · below model
DPG
Valuation N/A
Duff & Phelps Utility & Infrastructure Fund Inc.
Price$13.91
Model IV—
P/IV—
DPRO
Valuation N/A
Draganfly Inc.
Price$5.61
Model IV—
P/IV—
DPZ
Deeply undervalued
DOMINOS PIZZA INC
Price$294.20
Model IV$662.56
P/IV0.47
Discount 56%
Return to IV: +125.2%
Owner yield 5.5%
10-yr IRR 10.7% · moderate
Market implies -3.6%/yr
vs model +7.6% · below model
DQ
Valuation N/A
DAQO NEW ENERGY CORP.
Price$11.54
Model IV—
P/IV—
Market implies +41.0%/yr
vs model +2.0% · above model
DRCT
Valuation N/A
Direct Digital Holdings, Inc.
Price$1.71
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +2.0% · below model
DRD
Valuation N/A
DRDGOLD LTD
Price$26.81
Model IV—
P/IV—
DRDB
Valuation N/A
Roman DBDR Acquisition Corp. II
Price$10.67
Model IV—
P/IV—
DRDBU
Valuation N/A
Roman DBDR Acquisition Corp. II
Price$10.72
Model IV—
P/IV—
DRDBW
Valuation N/A
Roman DBDR Acquisition Corp. II
Price$0.17
Model IV—
P/IV—
DRH
Deeply overvalued
DiamondRock Hospitality Co
Price$12.20
Model IV$8.41
P/IV1.31
Premium +45%
Return to IV: -31.1%
DRI
Deeply undervalued
DARDEN RESTAURANTS INC
Price$209.28
Model IV$315.97
P/IV0.65
Discount 34%
Return to IV: +51.0%
Owner yield 4.1%
10-yr IRR 12.0% · grower
Market implies +6.0%/yr
vs model +14.7% · below model
DRIO
Fairly valued
DarioHealth Corp.
Price$6.93
Model IV$7.61
P/IV1.02
Discount 9%
Return to IV: +9.8%
Market implies -10.4%/yr
vs model +2.2% · below model
DRMA
Valuation N/A
Dermata Therapeutics, Inc.
Price$1.19
Model IV—
P/IV—
DRMAW
Valuation N/A
DRMAW
Price$0.00
Model IV—
P/IV—
DRS
Deeply overvalued
Leonardo DRS, Inc.
Price$36.07
Model IV$11.71
P/IV4.17
Premium +208%
Return to IV: -67.5%
Owner yield 1.9%
10-yr IRR -3.6% · moderate
Market implies +20.5%/yr
vs model +6.1% · above model
DRTS
Valuation N/A
Alpha Tau Medical Ltd.
Price$14.43
Model IV—
P/IV—
DRTSW
Valuation N/A
Alpha Tau Medical Ltd.
Price$3.84
Model IV—
P/IV—
DRUG
Valuation N/A
BRIGHT MINDS BIOSCIENCES INC.
Price$63.38
Model IV—
P/IV—
DRVN
Deeply overvalued
Driven Brands Holdings Inc.
Price$12.15
Model IV$20.79
P/IV2.28
Discount 42%
Return to IV: +71.1%
Market implies -12.8%/yr
vs model +6.1% · below model
DSAC
Valuation N/A
Daedalus Special Acquisition Corp.
Price$10.17
Model IV—
P/IV—
DSACU
Valuation N/A
Daedalus Special Acquisition Corp.
Price$10.30
Model IV—
P/IV—
DSACW
Valuation N/A
Daedalus Special Acquisition Corp.
Price$0.80
Model IV—
P/IV—
DSGN
Valuation N/A
Design Therapeutics, Inc.
Price$14.63
Model IV—
P/IV—